UBS Group’s FT Vest US Equity Enhance & Moderate Buffer ETF November XNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-162
Closed -$6.06K 11115
2026
Q1
$6.06K Sell
162
-111
-41% -$4.21K ﹤0.01% 8719
2025
Q4
$10.3K Buy
+273
New +$10.2K ﹤0.01% 8226
2025
Q3
Sell
-2,557
Closed -$90.9K 11021
2025
Q2
$90.9K Buy
2,557
+2,489
+3,660% +$84.8K ﹤0.01% 7319
2025
Q1
$2.29K Buy
+68
New +$2.33K ﹤0.01% 9364
2024
Q4
Sell
-159
Closed -$5.35K 10481
2024
Q3
$5.35K Sell
159
-1,027
-87% -$34.2K ﹤0.01% 8064
2024
Q2
$39.2K Sell
1,186
-2,485
-68% -$81.1K ﹤0.01% 6875
2024
Q1
$119K Buy
+3,671
New +$117K ﹤0.01% 6142

Other funds holding XNOV

UBS Group's XNOV Position: Q2 2026 in Review

UBS Group sold out of FT Vest US Equity Enhance & Moderate Buffer ETF November (XNOV) in Q2 2026, closing a stake of 162 shares — an estimated $6.06K sold.

UBS Group first reported a position in XNOV in Q1 2024 and held it in 7 quarters. The position peaked at $119K in Q1 2024. 34 funds tracked by Wall St. Rank hold XNOV as of Q2 2026.

  • UBS Group reported no remaining FT Vest US Equity Enhance & Moderate Buffer ETF November position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 162 FT Vest US Equity Enhance & Moderate Buffer ETF November shares in Q2 2026, an estimated $6.06K.
  • UBS Group first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF November in Q1 2024 and held it in 7 quarters.
  • UBS Group's FT Vest US Equity Enhance & Moderate Buffer ETF November position peaked at $119K in Q1 2024.
  • 34 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF November as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.